Cargando…
Low levels of the key B cell activation marker, HLA-DR, in COVID-19 hospitalized cases are associated with disease severity, dexamethasone treatment, and circulating IL-6 levels
Autores principales: | Dobi, Anthony, Dubernet, Arthur, Rakoto, Mahary Lalarizo, Seteyen, Anne-Laure Sandenon, Vagner, Damien, Lebeau, Grégorie, Raffray, Loïc, Gasque, Philippe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9178219/ https://www.ncbi.nlm.nih.gov/pubmed/35679009 http://dx.doi.org/10.1007/s12026-022-09269-w |
Ejemplares similares
-
Serological Surveillance of COVID-19 Hospitalized Patients in Réunion Island (France) Revealed that Specific Immunoglobulin G Are Rapidly Vanishing in Severe Cases
por: Dobi, Anthony, et al.
Publicado: (2020) -
Robust and low-cost ELISA based on IgG-Fc tagged recombinant proteins to screen for anti-SARS-CoV-2 antibodies
por: Frumence, Etienne, et al.
Publicado: (2021) -
Deciphering SARS-CoV-2 Virologic and Immunologic Features
por: Lebeau, Grégorie, et al.
Publicado: (2020) -
In Vitro Analyses of the Multifocal Effects of Natural Alkaloids Berberine, Matrine, and Tabersonine against the O’nyong-nyong Arthritogenic Alphavirus Infection and Inflammation
por: Sandenon Seteyen, Anne-Laure, et al.
Publicado: (2023) -
Anti-Alphaviral Alkaloids: Focus on Some Isoquinolines, Indoles and Quinolizidines
por: Sandenon Seteyen, Anne-Laure, et al.
Publicado: (2022)